UY33417A - Formulación que contiene acido azelaico con adición de pigmento - Google Patents

Formulación que contiene acido azelaico con adición de pigmento

Info

Publication number
UY33417A
UY33417A UY0001033417A UY33417A UY33417A UY 33417 A UY33417 A UY 33417A UY 0001033417 A UY0001033417 A UY 0001033417A UY 33417 A UY33417 A UY 33417A UY 33417 A UY33417 A UY 33417A
Authority
UY
Uruguay
Prior art keywords
azelaic acid
addition
pigment
formulation containing
containing azelaic
Prior art date
Application number
UY0001033417A
Other languages
English (en)
Inventor
Timm Schmidt
Dr Thomas Zollner
Dr Mairkus Friedrich
Original Assignee
Intendis Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intendis Gmbh filed Critical Intendis Gmbh
Publication of UY33417A publication Critical patent/UY33417A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente solicitud de patente se refiere a una composición farmacéutica que contiene ácido azelaico, preferentemente un gel que contiene ácido azelaico, con adición de pigmentos que, entre otras cosas, se puede usar para el tratamiento de la rosácea y el acné, así como a un procedimiento para su preparación.
UY0001033417A 2010-05-27 2011-05-27 Formulación que contiene acido azelaico con adición de pigmento UY33417A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102010021671A DE102010021671A1 (de) 2010-05-27 2010-05-27 Azelainsäurehaltige Formulierung mit Pigmentzusatz

Publications (1)

Publication Number Publication Date
UY33417A true UY33417A (es) 2011-12-30

Family

ID=44201041

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001033417A UY33417A (es) 2010-05-27 2011-05-27 Formulación que contiene acido azelaico con adición de pigmento

Country Status (5)

Country Link
US (1) US20120027862A1 (es)
DE (1) DE102010021671A1 (es)
TW (1) TW201208670A (es)
UY (1) UY33417A (es)
WO (1) WO2011147964A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8876965B2 (en) * 2012-05-09 2014-11-04 J.M. Huber Corporation Blended opacifier for coatings and polymeric matrices
ITMI20130354A1 (it) 2013-03-08 2014-09-09 Again Life Italia Srl Miscela di acidi grassi (f.a.g. fatty acids group) per uso nel trattamento di patologie infiammatorie.
US9320687B2 (en) 2013-03-13 2016-04-26 Johnson & Johnson Consumer Inc. Pigmented skin-care compositions
US9168209B2 (en) 2013-03-13 2015-10-27 Johnson & Johnson Consumer Inc. Pigmented skin-care compositions
US9168393B2 (en) 2013-03-13 2015-10-27 Johnson & Johnson Consumer Inc. Pigmented skin-care compositions
US9168394B2 (en) 2013-03-13 2015-10-27 Johnson & Johnson Consumer Inc. Pigmented skin-care compositions
JP6900496B2 (ja) * 2017-09-28 2021-07-07 株式会社マンダム 半固体状洗浄剤
EP4297743A1 (en) * 2021-02-25 2024-01-03 Exinov Emulsion for use in the treatment of rosacea
CN115501171A (zh) * 2021-11-02 2022-12-23 上海丽舒丹医药科技有限公司 一种高浓度壬二酸乳膏及其制备工艺

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4386104A (en) * 1977-04-19 1983-05-31 Nazzaro Porro Marcella Process for the treatment of acne
IT1075741B (it) 1977-04-19 1985-04-22 Porro Marcella Composizione per il trattamento di dermatosi iperpigmentarie
DE3623862A1 (de) 1986-07-11 1988-01-21 Schering Ag Verwendung von dicarbonsaeuren mit 7 - 13 kohlenstoffatomen oder physiologisch vertraeglichen salzen davon zur topischen behandlung von rosazea
DE3811081A1 (de) 1988-03-30 1989-10-12 Schering Ag Verwendung von topisch applizierbaren praeparaten zur behandlung der altershaut
US5871754A (en) * 1993-08-06 1999-02-16 The Procter & Gamble Company Cosmetic compositions
GB9405322D0 (en) * 1994-03-18 1994-04-27 Procter & Gamble Powder cosmetic compositions
ES2169566T3 (es) * 1997-11-19 2002-07-01 Schering Ag Composicion con acido azelaico.
DE19857491A1 (de) * 1998-12-14 2000-06-15 Hans Lautenschlaeger Hautschutzpräparate zur Prävention von Hautschäden mit UV-Filtern
US7299885B2 (en) 2002-07-10 2007-11-27 Baird Jeffery D Downhole drill string having a collapsible subassembly and method of loosening a stuck drillstring
DE502004004660D1 (de) 2003-06-10 2007-09-27 Intendis Gmbh Zusammensetzung aus alkandicarbonsäuren und einem pharmazeutischen wirkstoff
US7695726B2 (en) * 2004-01-23 2010-04-13 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Pigmented cosmetic composition exhibiting radiance with soft focus
EP1948236B1 (en) * 2005-09-27 2021-03-03 Special Water Patents B.V. Methods and compositions for treatment of skin
WO2007083174A1 (en) * 2006-01-20 2007-07-26 Carlo Ghisalberti Curative pigments and make-up comprising thereof
DE102006004804A1 (de) 2006-01-23 2007-07-26 Intendis Gmbh Verwendung von Alkandicarbonsäuren und Retinoiden zur Behandlung entzündlicher Hauterkrankungen
DE102007005093A1 (de) * 2007-01-25 2008-07-31 Beiersdorf Ag Kosmetische Zubereitung gegen Hautpigmentierungen

Also Published As

Publication number Publication date
TW201208670A (en) 2012-03-01
WO2011147964A1 (de) 2011-12-01
DE102010021671A1 (de) 2011-12-01
US20120027862A1 (en) 2012-02-02

Similar Documents

Publication Publication Date Title
UY33417A (es) Formulación que contiene acido azelaico con adición de pigmento
UY33776A (es) Ácidos 1-bencilcicloalquilcarboxílicos sustituidos y su uso
CO7240369A2 (es) Ácido 5-aminotetrahidroquinolin-2-carboxílicos novedosos y su uso
CL2016000882A1 (es) Composiciones de arni contra el componente c5 del complemento y métodos para su uso (divisional de sol. n°2710-15).
GT201500051A (es) Inhibidores de glucosilceramida sintasa
DOP2011000285A (es) 2-acetamido-5-aril-1, 2, 4-triazolonas sustituidas y su uso
AR091465A1 (es) Una composicion farmaceutica que contiene acido nicotinico y/o nicotinamida y/o triptofano para influenciar positivamente la microbiota intestinal
BR112013006044A2 (pt) materiais e métodos para melhorar a função gastrointestinal.
CR20150174A (es) Composición esterilizada que comprende al menos un ácido hialuronico y ascorbil fosfato de magnesio
UY32970A (es) Acidos 3-fenilpropionicos sustituidos y su uso
DOP2014000170A (es) Compuestos de imidazopirrolidinona
ECSP12012310A (es) 5-fluoro-1h-pirazolopiridinas sustituidas y su uso
ECSP13012978A (es) Inhibidores de glucosilceramida sintasa
UY35115A (es) Imidazo[1,2-a]piridincarboxamidas aminosustituidas y su uso
DOP2013000239A (es) Derivados de ácido 3-fenilpropiónico ramificados y su uso.
BR112015001101A2 (pt) formas cristalinas de um inibidor de prolil hidroxilase
MX352823B (es) Formulaciones de proteinas que contienen aminoacidos.
PE20150627A1 (es) Derivados de c17-alcandiilo y alquendiilo del acido oleanolico y sus metodos de uso
CR20140513A (es) Uracilos sustituidos bicíclicamente y uso de los mismos
UY31228A1 (es) Ariloxazoles sustituidos y su uso
CL2016000950A1 (es) Composición farmacéutica acuosa que comprende insulina glulisina y metionina; kit farmacéutico; uso en el tratamiento de la diabetes tipo 1 ó 2.
ECSP11011082A (es) Compuestos, composición farmaceutica y métodos para utilizarse en el tratamiento de desórdenes metabólicos
CL2013000735A1 (es) Uso de una composicion que comprende compuestos derivados de 1-h-imidazol-4-il sustituido para el tratamiento de enfermedades y condiciones de la piel, tales como rosacea, daño solar cronico, psoriasis, entre otras; kit farmaceutico.
BR112012029946A2 (pt) encapsulação de ingredientes em matriz de lactose para formar encapsulados ativos
BR112014027047A2 (pt) nova formulação

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20200629